These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 484965)

  • 21. [Diagnosis of renovascular hypertension].
    Filipecki S; Bar-Andziak E; Malanowska S
    Pol Arch Med Wewn; 1979 Nov; 62(5):455-9. PubMed ID: 394122
    [No Abstract]   [Full Text] [Related]  

  • 22. Saralasin acetate test in renal transplant hypertension. Report of 17 cases and a review of the literature.
    Zawada ET; Green SJ; Johnson MD; Reinitz ER; Mauakkassa W; Sica D; Goldman M
    Arch Intern Med; 1984 Jan; 144(1):65-8. PubMed ID: 6362596
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical experience with saralasin infusion in hypertensive patients.
    Tegtmeyer CJ; Latour EA; Vaughan ED; Ayers CR; Carey RM; Wellons HA
    Invest Radiol; 1977; 12(6):496-504. PubMed ID: 591250
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The angiotensin infusion test and peripheral venous renin activity.
    Silah JG; Strong CG; Nowaczynski W; Genest J
    Can Med Assoc J; 1967 May; 96(21):1397-400. PubMed ID: 4290836
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Screening of angiotensin II dependent hypertensive patients using a linear classifier.
    Koivo AJ
    Med Inform (Lond); 1981; 6(1):19-24. PubMed ID: 7015036
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnostic value of captopril test in hypertensive patients with renal artery stenosis.
    Takata M; Yoshida K; Tomoda F; Oh-hashi S; Ueno H; Yasumoto K; Iida H; Sasayama S
    Angiology; 1994 Mar; 45(3):181-6. PubMed ID: 8129198
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnosis of angiotensinogenic hypertension: the complementary roles of renal scintigraphy and the saralasin infusion test.
    McAfee JG; Thomas FD; Grossman Z; Streeten DH; Dailey E; Gagne G
    J Nucl Med; 1977 Jul; 18(7):669-75. PubMed ID: 874145
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Advances in diagnosis and treatment of renovascular hypertension.
    Gruenewald SM; Stewart JH; Crocker EF
    Med J Aust; 1983 Jun; 1(12):572-4. PubMed ID: 6222249
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Abnormal adrenal responsiveness and angiotensin II dependency in high renin essential hypertension.
    Dluhy RG; Bavli SZ; Leung FK; Solomon HS; Moore TJ; Hollenberg NK; Williams GH
    J Clin Invest; 1979 Nov; 64(5):1270-6. PubMed ID: 500810
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Significance of the saralasin infusion test in the diagnosis of arterial hypertension].
    Glorioso N; Madeddu P; Dessì-Fulgheri P; Meloni F; Palermo M; Fiori C; Rappelli A
    Boll Soc Ital Cardiol; 1980; 25(9):1035-46. PubMed ID: 7025868
    [No Abstract]   [Full Text] [Related]  

  • 31. [Renovascular hypertension: diagnosis and surgical treatment].
    Martínez-Piñeiro JA
    Arch Esp Urol; 1981; 34(5):317-38. PubMed ID: 7036918
    [No Abstract]   [Full Text] [Related]  

  • 32. Maximal discrimination of renovascular from essential hypertension by the saralasin test.
    Maxwell MH; Varady P; Zawada ET; Burkhalter JF; Waks U; Marks L
    Clin Sci Mol Med Suppl; 1978 Dec; 4():297s-299s. PubMed ID: 282071
    [No Abstract]   [Full Text] [Related]  

  • 33. [Clinical usefulness of saralasin in human hypertension (author's transl)].
    Fouchard M; Bichara M; Grüfeld JP; Barbanel C; Meyer P; Funck-Brentano JL
    Nouv Presse Med; 1978 Feb; 7(7):539-43. PubMed ID: 643579
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effect of saralasin on normal blood pressure and on reno-vascular hypertension (author's transl)].
    Beckerhoff R; Vetter W; Furrer J; Nussberger J; Schmied U; Siegenthaler W
    Dtsch Med Wochenschr; 1976 Mar; 101(11):398-401. PubMed ID: 1253700
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The diagnosis and treatment of renovascular hypertension.
    Streeten DH; Anderson GH; Bredenberg CE; Randall P
    Clin Invest Med; 1978; 1(3-4):155-61. PubMed ID: 391454
    [No Abstract]   [Full Text] [Related]  

  • 36. [Dynamic evaluation of the renin-angiotensin system with captopril in screening for renovascular hypertension].
    Rossi G; Semplicini A; Pessina AC; Perissinotto F; De Toni R; Feltrin G; Mozzato MG; Dal Palù C
    G Ital Cardiol; 1985 May; 15(5):472-7. PubMed ID: 3902548
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DIgital intravenous subtraction angiography for investigating renovascular hypertension: comparison with hypertensive urography.
    Dunnick NR; Ford KK; Johnson GA; Gunnells JC
    South Med J; 1985 Jun; 78(6):690-3. PubMed ID: 3890201
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New approaches to the diagnosis of renovascular hypertension.
    Maxwell MH; Rudnick MR; Waks AU
    Adv Nephrol Necker Hosp; 1985; 14():285-304. PubMed ID: 3919536
    [No Abstract]   [Full Text] [Related]  

  • 39. Use of saralasin in end-stage renal disease.
    Fadem SZ; Lifschitz MD
    Kidney Int Suppl; 1979 Mar; (9):S93-100. PubMed ID: 289869
    [No Abstract]   [Full Text] [Related]  

  • 40. [The captopril test--an aid in the detection of scarring nephropathy as a cause of arterial hypertension in children].
    Peco-Antić A; Nastić-Mirić D; Babić D; Kostić M
    Srp Arh Celok Lek; 1999; 127(9-10):305-11. PubMed ID: 10649899
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.